ClinVar Miner

Submissions for variant NM_024598.4(USB1):c.266-1G>A

dbSNP: rs1555498092
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001384478 SCV001583983 pathogenic not provided 2020-06-13 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in USB1 are known to be pathogenic (PMID: 20817924, 25044170). Experimental studies have shown that this variant disrupts mRNA splicing (PMID: 21271650). This variant has been observed in individual(s) with poikiloderma with neutropenia (PMID: 21271650, 21967010). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 496754). This variant is not present in population databases (ExAC no frequency). This sequence change affects an acceptor splice site in intron 2 of the USB1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000599282 SCV005040434 pathogenic Poikiloderma with neutropenia 2024-03-04 criteria provided, single submitter clinical testing Variant summary: USB1 c.266-1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a canonical 3' acceptor site. At least one publication reports experimental evidence that this variant affects mRNA splicing (Clericuzio_2011). The variant was absent in 251484 control chromosomes (gnomAD). c.266-1G>A has been reported in the literature in individuals affected with Poikiloderma With Neutropenia (example: Clericuzio_2011, Rattanavalai_2012). These data indicate that the variant is likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 21271650, 21967010). ClinVar contains an entry for this variant (Variation ID: 496754). Based on the evidence outlined above, the variant was classified as pathogenic.
GeneReviews RCV000599282 SCV000700243 not provided Poikiloderma with neutropenia no assertion provided literature only
OMIM RCV000599282 SCV001981671 pathogenic Poikiloderma with neutropenia 2021-10-20 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.